Package 65219-190-30

{"route": ["INTRAVENOUS"], "spl_id": "93859f2f-4d62-4b6f-94bc-a3f5d4ed9890", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "unii": ["JFU09I87TR"], "rxcui": ["351209"], "spl_set_id": ["25eb8d91-5abd-4fdb-a331-dacc960a95d9"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (65219-190-30)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "65219-190-30", "marketing_start_date": "20201201"}], "brand_name": "Voriconazole", "product_id": "65219-190_93859f2f-4d62-4b6f-94bc-a3f5d4ed9890", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "65219-190", "generic_name": "Voriconazole", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Voriconazole", "active_ingredients": [{"name": "VORICONAZOLE", "strength": "10 mg/mL"}], "application_number": "ANDA211099", "marketing_category": "ANDA", "marketing_start_date": "20201201", "listing_expiration_date": "20261231"}